Exor N.V. holds a concentrated book of 3 stocks worth $5.4B as of Q1 2026 (disclosed May 13, 2026, a ~45-day 13F lag). The SEC 13F shows only Exor N.V.'s US-listed positions. Its main portfolio is mostly Amsterdam/Milan-listed and does not appear in this book. Their largest long position is Koninklijke Philips N V at 93% of the equity book. Cloning the disclosed picks since 2026 would be +10%. That is a simulation of the disclosed long book, not audited returns.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1589122/holdings"
Use Arkolith to show Exor N.V.'s latest holdings, largest changes, and filing provenance.
Following at the filing date actually beat the quarter-end book by 8.6 points over this window.
Growth of $10,000 cloning Exor N.V.'s disclosed long 13F book, rebalanced on each filing date (so it reflects the ~45-day reporting lag, no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
7% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Other tracked managers holding the same core names as Exor N.V.
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| BlackRock, Inc. | 2 / 3 | $63.6M |
| VANGUARD GROUP INC | 2 / 3 | $58.8M |
| Ken Griffin | 2 / 3 | $53.2M |
| UBS Group AG | 2 / 3 | $25.9M |
| STATE STREET CORP | 2 / 3 | $22.1M |
| MORGAN STANLEY | 2 / 3 | $21.3M |
| GEODE CAPITAL MANAGEMENT, LLC | 2 / 3 | $21.2M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2 / 3 | $20.8M |
Ranked by how many of Exor N.V.'s top 3 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Koninklijke Philips N V NY REGIS SHS NEW | $5.0B | 182.54M | 92.9% | —Held | |
| 2 | Via Transn Inc COM CL A | $211.8M | 14.12M | 3.9% | —Held | |
| 3 | Clarivate PLC ORD SHS | $170.3M | 67.29M | 3.2% | —Held |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 13, 2026 | 3 | $5.4B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 3, 2026 | 3 | $5.6B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 12, 2025 | 3 | $5.9B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Jul 16, 2025 | 2 | $4.7B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 8, 2025 | 2 | $4.7B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 22, 2025 | 2 | $4.5B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Oct 17, 2024 | 2 | $5.9B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Jul 9, 2024 | 2 | $4.5B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | Apr 16, 2024 | 2 | $3.3B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 12, 2024 | 2 | $3.9B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 8, 2023 | 2 | $3.0B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 | 2 | $905.4M | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 | 1 | $304.9M | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 14, 2023 | 1 | $139.0M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.